Clinical trials
Phase 2 Diabetes Mellitus, Type 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 8 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Unknown status | 10 |
| Recruiting | 5 |
| Not yet recruiting | 5 |
| Active, not recruiting | 4 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jiangsu HengRui Medicine Co., Ltd. | 9 |
| Gan and Lee Pharmaceuticals, USA | 4 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 2 |
| Gan & Lee Pharmaceuticals. | 2 |
| Haisco Pharmaceutical Group Co., Ltd. | 2 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2 |
| Shandong Suncadia Medicine Co., Ltd. | 2 |
| Shanghai Jiao Tong University School of Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 56 |
| Diabetes Mellitus | 6 |
| Obesity | 3 |
| Overweight | 3 |
| Diabetes Mellitus, Type 1 | 1 |
| Diabetic Nephropathies | 1 |
| Insulin Resistance | 1 |
| Weight Loss | 1 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.